There have been reports of alopecia, a.k.a. hair loss, linked to GLP-1 use. And following an FDA investigation of post-market ...
Selected devices will be exempt from certain premarket requirements while manufacturers collect real-world data through Medicare.
Federal health advisers are meeting to review a group of controversial chemicals called peptides. The unapproved injections have become a popular wellness trend, promoted by influencers and ...